DYRK2 and neoplasm: Furthermore, cancer cell lines and patient tumor tissues are cancerous; therefore, it is difficult to determine whether tumorigenesis and/or tumor development cause changes in DYRK2 expression or whether changes in DYRK2 expression cause tumorigenesis and/or tumor development.